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NON-STEROIDAL ANTI-INFLAMMATORY DRUGS INCREASE RECURRENCE 
RISK FOLLOWING SURGICAL PLEURODESIS FOR PRIMARY PNEUMOTHORAX 
Peter Yu, H. Lim, N. Yam, A. Sihoe 
 
Department of Surgery, The University of Hong Kong, Hong Kong 
 
OBJECTIVES: Non-steroidal anti-inflammatory drugs (NSAID) have been shown to reduce the 
histopathological quality of pleurodesis in animal studies, but their effect on pleurodesis in 
humans has not been investigated. METHODS: During January 1999 - January 2003 - when 
NSAIDs were still commonly used following pneumothorax surgery - 176 consecutive patients 
received video-assisted thoracic surgery (VATS) pleurodesis for primary pneumothorax 
(exclusions: secondary pneumothorax or previous pleurodesis). Recurrence defined as any new 
clinically or radiographically detected ipsilateral pneumothorax following surgery was 
documented. RESULTS: At the surgeon’s discretion, an NSAID (Naproxen) was used for 
postoperative analgesia in 44 patients (25%). All major demographic and clinical factors were 
similar amongst the NSAID and control patients. After a median follow-up of 162.4 months 
(range 143-191 months), 11 patients (25%) in the NSAID group had recurrence, compared to 12 
patients (9%) in the control group (HR = 2.97 [95% CI 1.14-7.79], P = 0.006). Life table analyses 
demonstrated no significant effect of NSAID on recurrence in the first 6 months (HR = 2.50 [95% 
CI 0.64-9.77], P = 0.118), but significantly higher recurrence at 9 months (HR = 3.54 [95% CI 
1.01-12.48], P = 0.015) and thereafter. History of smoking is paradoxically associated with lower 
recurrence risk (HR = 6.17 [95% CI 2.72-13.97], P < 0.001). The effect of NSAID on recurrence 
is more pronounced in non-smokers (HR = 3.46 [95% CI 1.21-9.89], P = 0.003), but not 
significant in smokers (HR = 1.53 [95% CI 0.11-21.24], P = 0.725). The mean total dose of 
NSAID use showed a trend of association with recurrence (Recurrence: 2113 mg; No recurrence: 
1803 mg; P = 0.053). Recurrence was not correlated with any other demographic or clinical 
variables. Use of NSAID failed to reduce pain scores on postoperative day 1. CONCLUSIONS: 
Use of NSAIDs after surgical pleurodesis for primary pneumothorax increases recurrence risk, 
while being ineffective in pain control. Routine NSAIDs use following surgical pleurodesis 
should be avoided, particularly for non-smokers. 
